Ole Solheim

Malurt

[Ole Solheim @solheim_ole]

Penetrating Traumatic Brain Injury in Children in the Gaza Strip https://t.co/mm9SPCHu2J

[Asgeir Jakola @AsgeirJakola]

Timely review 📖 @DrAMansouri
mIDH inhibitors like vorasidenib delay progression in IDH-mut gliomas, but data on survival, QoL & cognition still lacking.
Proton therapy? Promising in theory.
We need to stay focused on what matters 🧠👥
🔗 https://t.co/QQ9OT4TxLC
#braincancer

[Mímir Kristjánsson @mimirk]

Bare en påminnelse om at Norge har flere helsedirektører (333) enn intensivplasser (278).

Helt hundre prosent fullstendig klin kokos.

https://t.co/dfGbWkDXxw

[No Lie with Brian Tyler Cohen @NoLieWithBTC]

Thousands of Danish citizens are launching an effort to buy California as a response to Trump’s attempt to take Greenland.

They say they will provide Californians with “rule of law, universal health care, fact-based politics, and a lifetime supply of Danish pastries.”

[Nicholas Fabiano, MD @NTFabiano]

Since legalization, new schizophrenia cases linked to heavy cannabis use have tripled.

🧵1/9

[Journal of Neurosurgery @TheJNS]

#OnlineFirst: Prognostic value of manual versus automatic methods for assessing extents of resection and residual tumor volume in glioblastoma.

https://t.co/JRKsc6lZ42.

[Ole Solheim @solheim_ole]

Den innbilte effekten av epidural ryggmargsstimulering | Tidsskrift for Den norske legeforening https://t.co/IOFJXpQpPD

[Ole Solheim @solheim_ole]

Progression-free survival - a valid endpoint in low grade glioma? #Vorasidenib #PFS ⁦@VPrasadMDMPH⁩ https://t.co/g2sMmYKaxM

[Regional Anesthesia & Pain Medicine @RAPMOnline]

🔍 New study reveals 78.9% of spinal cord stimulation RCTs reported conflicts of interest (COIs), with 76.3% having undisclosed COIs.

This calls for stronger COI policies to uphold integrity in neuromodulation research.

https://t.co/10ASiahKDj

@Ryan_S_DSouzaMD @JohanaKlasova

[Ole Solheim @solheim_ole]

@clemensweber A very overtreated fracture. In low energy type 2 fractures, do patients even need collars? Most of these are osteoporotic fractures in the elderly that never heal - and it does not really matter. Few have plan and late myelopathy is never seen.

[The BMJ @bmj_latest]

Is decompression alone non-inferior to decompression with instrumented fusion in patients with degenerative lumbar spondylolisthesis?

New randomised trial investigates @AustevollIvar
https://t.co/RUaPOukO8J

[National Brain Tumor Society @NBTStweets]

Exciting News! Vorasidenib (brand name: Voranigo) has just been approved by the FDA for the treatment of adult and pediatric patients 12 years of age and older with grade 2 astrocytoma or oligodendroglioma with an IDH1 or IDH2 mutation. Read more: https://t.co/G6FB95R7nj

[Ole Solheim @solheim_ole]

@NaderSanai @MTouatMD Since the RTOG9802 trial from 2016 the evidence for RT/PCV has been far stronger than for RT/TMZ. Still, many have chosen the latter as standard treatment. This has not been evidence based practice, and as seen, not benefical for the patients.

[Alec Stapp @AlecStapp]

Occasional reminder that there are no low energy, rich countries

[Richard Smith @Richard56]

Another example of medicalisation of suffering when a medical response is not the best response. (Shameful as well that basic data on age and gender are missing.) https://t.co/sMp9ibFCX0

[Vinay Prasad MD MPH @VPrasadMDMPH]

CAR-T kills more people early
Population was *NOT* heavily pretreated
OS is not significantly improved
Data are too immature for OS analysis
What does the FDA do?
11-0!

If anything, with emerging alternative options, CAR-T should move BACK in lines of therapy

[Vinay Prasad MD MPH @VPrasadMDMPH]

8-3 vote on a IDA Cel
Drug doesn't improve survival
Clearly OS curves look like they will never be positive
Tons of toxicity, early death
Astonishingly low standards in Cancer medicine

[NEJM @NEJM]

Patients with evidence of microplastics and nanoplastics in carotid artery plaque, as compared with patients without, had a greater risk of adverse cardiovascular events at 34 months of follow-up. Read the full article: https://t.co/BUsdzHMcdb

[Asgeir Jakola @AsgeirJakola]

Looking forward to meet Scandinavian/Nordic neuro-oncology friends in April 🇫🇮🇩🇰🇸🇪 🇳🇴🇮🇸: https://t.co/4STt2UwbjR Present, interact, collaborate, socialize👩‍⚕️👨🏾‍🎓👩🏼‍💻👩🏾‍🔬👨🏻‍🏫at this exciting newly opened venue: https://t.co/043mK8mFFx